USP Monograph Changes Could Be Strategy To Impede Generic Entry
Executive Summary
Modifications to a branded drug's U.S. Pharmacopeia monograph could pose impediments to generic entry, Frommer, Lawrence & Haug attorney Andrew Berdon said
You may also be interested in...
Organon Contraceptive Maneuverings: NuvaRing, Implanon To Drive Growth
Organon expects a pre-approval inspection for the implantable contraceptive Implanon during the first half of 2003
Organon Contraceptive Maneuverings: NuvaRing, Implanon To Drive Growth
Organon expects a pre-approval inspection for the implantable contraceptive Implanon during the first half of 2003
Antitrust Scrutiny Of Patent Listings Could Undo Waxman/Hatch – Attorney
A recent district court decision regarding Bristol's BuSpar allowing antitrust claims against the company to proceed could undermine Waxman/Hatch by discouraging companies from listing patents in the Orange Book, Ropes & Gray attorney James Spears said